Hong Kong-based startup PanopticAI has obtained regulatory approval in the United States for its contactless pulse rate measuring application. It received the US Food and Drug Administration’s 510(k) clearance for the PanopticAI Vital Signs app…
Continue Reading
Dr. Keith Thompson, Chief Medical Officer of NuraLogix Those of us old enough to recall the 1960s TV series “Star Trek” were fascinated by Dr. McCoy when he would simply point a scanner at…
Continue Reading
NuraLogix has announced new capability for assessing fatty liver disease risk, using its contactless health platform that measures vital signs and provides health risk assessments.The company’s researchers have developed artificial intelligence (AI) models that…
Continue Reading
